FlexSpine

FlexSpine was a medical device company focused on the development of motion-preserving spinal implants for the treatment of lumbar spine conditions. The company's flagship product, the FlexSpine Core, was a total facet arthroplasty system designed to stabilize the spine while maintaining natural flexibility, serving as an alternative to traditional spinal fusion. This technology specifically targeted patients suffering from lumbar spinal stenosis, degenerative disc disease, and spondylolisthesis. FlexSpine advanced its lead candidate into clinical trials under an FDA Investigational Device Exemption (IDE). Despite its innovative approach to spinal biomechanics, the company is currently inactive.